久久久精品欧美一区二区三区,国产欧美久久久精品影院,亚洲AV福利天堂一区二区三亚洲欧洲日韩国产AⅤ在线,亚洲成av人在线视,四虎国产精品永久地址99自拍三区一级国产片,亚洲男人的天堂久久无在线观看免费黄视频,亚洲一级特黄大片在线播放,国产成人精品区在线观看

Vaccine
Home > Application > Vaccine > Virus-like particle (VLP) vaccine

Virus-like particle (VLP) vaccine

Most currently available vaccines are mainly based on inactivated or attenuated live vaccines. Although these traditional vaccines have been used effectively against various infectious diseases, some of them have several limitations, including low likelihood of inducing a stronger immune response and their poor efficacy. Recent outbreaks of infectious diseases demonstrate the need to develop robust vaccines to overcome these limitations. The main challenge is to develop new technical approaches and boost immunity without compromising safety, efficacy and tolerability. Recent advances in vaccines based on DNA, mRNA, and recombinant viral vectors provide effective vaccine development methods for difficult-to-target pathogens and control infectious disease outbreaks.


Virus-like particle (VLP) technology provides an alternative platform for the development of effective vaccines against serious infectious diseases, and it is being developed in parallel with vaccines based on mRNA and viral vectors. VLPs are also much more immunogenic than other subunit vaccines because they present repetitive epitopes on their surface, making them more reliably detectable by the immune system. On the other hand, subunit vaccines may be less immunogenic due to misfolding of the target antigen or insufficient presentation to the immune system, and moreover, they require adjuvants and repeated vaccinations to elicit an adequate immune response. The term virus-like particle was first described by Fraenkel-Conrat and Williams (1955) by recombining tobacco mosaic virus (TMV) particles from purified RNA and protein components. The potential of these nanostructures to induce potent immune responses was then further investigated. The VLP platform can overcome various problems typically associated with traditional vaccines; specifically, infectivity, reversion to virulent forms, mutation risk associated with live attenuated vaccines, and reduced immunogenicity, toxicity instability, low yield and long formulation time associated with inactivated vaccines.


These bio-inspired nanostructures feature repetitive and high-density antigens from different viruses, helping to trigger a strong immune response. Furthermore, these highly immunogenic molecules possess the self-assembling properties of viral proteins. They are biocompatible and have the potential for structural flexibility during synthesis. They can be chemically or genetically modified and exhibit increased stability, uniformity, and functionality, and are considered effective tools in various biomedical applications. Depending on the presence or absence of a lipid membrane, VLPs can be classified as either enveloped or nonenveloped.


However, some of the key challenges associated with VLPs are low stability, difficult downstream processes, high production costs, and sensitivity to environmental conditions. Many different VLPs have been synthesized in various expression systems, such as bacteria, yeast, mammalian cells, insect cells, and plants. VLP-based vaccines have the potential to be used to treat various infectious diseases, including HIV, influenza, hepatitis B, hepatitis E, malaria, Ebola virus, SARS-CoV-2, Zika virus, dengue fever, and foot-and-mouth disease, among others. Several VLP-based vaccines have been licensed and marketed, including Engerix-B? and Recombivax HB? for HBV, Gardasil? and Cervarix? for HPV, Hecolin? for HEV, and Mosquirix? for malaria.

Related Products
Contact Us
  • Tel.: +86 021 6434 0155
  • E-Mail: marketing@duoningbio.com
  • Address: Building 30, No. 1525 Minqiang Road, Songjiang District, Shanghai
Message

Copyright ? Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support: Reanod

WeChat
WeChat

Message-

Duoning Biotechnology

+86 021 6434 0155

亚洲 无码 AV 在线| 一区二区国产在线播放| 亚洲精品国产专区91在线| 国产色又爽视频免费播放| 2021精品久久久久精品免费网| 熟妇女人妻丰满少妇中文字幕| 精品国产三级大全在线观看| 国产人妖性一区二区| 亚洲一区二区不三区不卡| 亚洲中文字幕无码亚洲成a人片| 亚洲国产欧美日韩精品一区二区三区| 婷婷夜夜躁天天躁人人躁| 色欲av永久无码精品无码蜜桃| 欧美激情视频一区| 欧美最猛黑人xxxx黑人猛交| 色综合久久久久综合99| 日韩精品极品视频在线观看免费| 国产欧美日韩亚洲18禁在线| freesexvideos性少妇欧美| 国产在线高清理伦片a| 日本丰满妇人成熟免费中文字幕| 69久久夜色精品国产| 中文字幕在线免费看线人| 一本之道在线播放dvd国产| 欧洲成人午夜精品无码区久久| 国产AV日韩AⅤ亚洲AV无码馆| 午夜精品一区二区三区在线观看| 久久国产亚洲日韩一本| 在线精品一区亚洲毛片免费一级| 久久精品国产亚洲AV超碰| 九九99久久精品在免费线bt国内精品伊人久久久久| 日韩不卡毛片Av免费高清| 精品一区二区三区无码免费视频| 精品久久久久久综合日本| 久久久久精品青草线蕉综合| 午夜神马福利电影不卡在线a | 久久久性色精品国产免费观看| 精品亚洲AV无码 一区二区三区| 毛片大全真人在线| 国产精品爆乳奶水无码视频| 91精品人妻一区二区互动交流|